Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

Muscle fibers in children with SMA type 1 show substantial differences in components of the myosin protein called heavy ...

Interv Cardiol. 2014;6(1):57-69.

About a year ago, renal denervation procedures won a huge victory after finally being greenlit by FDA. Now two of the frontrunners in the space have received reimbursement.

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Patient and physician education is the next challenge to change the treatment paradigm for drug-resistant hypertension, Citi Research analyst Joanne Wuensch said.

Both Medtronic’s Symplicity Spyral and Recor’s Paradise renal denervation catheters were greenlighted by the FDA in November of last year, following more than a decade of research and ...

As part of its ongoing commitment to providing advanced medical care, Cleveland Clinic Abu Dhabi, part of the M42 group, has ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Centers for Medicare & Medicaid Services (CMS) has granted transitional pass-through (TPT) payment for the ...

The Medtronic Symplicty Spyral renal denervation system. [Illustration courtesy of Medtronic] Medtronic (NYSE:MDT) today announced new, long-term study data further supporting its Symplicity ...

Objectives To assess the effectiveness of radiofrequency denervation (RD) of lumbosacral anatomical targets for the management of chronic back pain. Design Systematic review and meta-analysis of ...

The U.S. Medicare outpatient final rule affirms several new devices for the new technology pass-through program, but one of the more significant findings is that CMS will use separate payment ...